During Wednesday’s Current trade, Shares of Cerner Corporation (NASDAQ:CERN), lost 0.83% to $71.89.
Cerner (CERN) declared it will release its second quarter 2015 earnings results after the market closes on August 4. There will be a conference call at 3:30 p.m. CT that can be accessed via dial-in or webcast.
The dial-in number for the conference call is (678) 509-7542; the passcode is Cerner. ‘
Cerner Corporation designs, develops, markets, installs, hosts, and supports healthcare information technology, healthcare devices, hardware, and content solutions for healthcare organizations and consumers in the United States and internationally. The company offers Cerner Millennium architecture, which comprises clinical, financial, and administration information systems that allow providers to access an individual’s electronic health record at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front and back-office professionals, and consumers.
Shares of Charter Communications, Inc. (NASDAQ:CHTR), declined -0.54% to $176.08, during its current trading session.
Charter Communications, Inc. (CHTR) released the following statement in response to the FCC’s Adoption of Lifeline Further Notice of Projected Rulemaking.
Charter applauds the FCC’s efforts to modernize and improve the Lifeline program to assist all Americans, regardless of income, access broadband services. They look forward to working with the FCC to develop a fiscally responsible program that encourages companies like Charter to take part by reducing administrative burdens, allowing them to focus on delivering high-quality broadband instead.
Charter Communications, Inc., through its auxiliaries, provides entertainment, information, and communications solutions to residential and commercial customers in the United States. The company offers cable video programming services, counting basic and digital video, premium channels, on-demand, pay-per-view, high definition television, and digital video recorder services, in addition to Charter TV App, which enables video customers to search and discover content on various devices, counting the iPhone, iPad, iPod Touch, and Android based tablets. It also provides Internet services, such as residential Internet services; Charter.net, an Internet portal that provides multiple e-mail addresses, in addition to various entertainment, games, news, and sports content; and Charter Security Suite, which protects computers from viruses and spyware, in addition to offers parental control features. In addition, the company provides telephone services comprising voice communications services primarily using voice over Internet protocol technology; broadband communications solutions comprising video entertainment services, Internet access, business telephone services, data networking, and fiber connectivity to cellular towers and office buildings for business and carrier organizations.
Akorn, Inc. (NASDAQ:AKRX), during its Wednesday’s current trading session gained 1.43% to $45.37.
Akorn, Inc. (AKRX), declared that the Nasdaq Stock Market has accepted the company’s plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) which will permit the continued listing of Akorn’s stock on the Nasdaq Global Select Market.
As formerly stated on May 18, 2015, Akorn received a letter from Nasdaq stating that the company was not in compliance with Nasdaq listing rules because the company had not filed its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2015 with the Securities and Exchange Commission. In the letter, Nasdaq requested that Akorn submit a plan to regain compliance with Nasdaq listing rules within 60 days.
Akorn, Inc. develops, manufactures, and markets generic and branded prescription pharmaceuticals, in addition to animal and over-the-counter (OTC) consumer health products in the United States and internationally. It operates through two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment markets generic and branded ophthalmics, injectables, oral liquids, otics, topical, inhalants, and nasal sprays. This segments generic products comprise Clobetasol Propionate, a corticosteroid, which is used to treat various skin conditions; Fluticasone Propionate, a corticosteroid used for nasal symptoms of allergic and non-allergic rhinitis conditions; Lidocaine/Prilocaine, a topical anesthetic; Progesterone, which is used to prevent endometrial hyperplasia; Vancomycin, an antibiotic used to treat bacterial infections; and other products. T
Finally, CIGNA Corporation (NYSE:CI), decreased -0.01%, to $155.94.
The Cigna Foundation will bring the spirit of partnership to Chicago as it hosts its first-ever World of Difference Summit on July 15-16 at the W Chicago, Lakeshore. The Summit will bring together the Cigna Foundation’s major non-profit grant partners working around the country, and around the world, in addition to many leading Chicago nonprofits, to “Spread the Health” by learning from each other and exploring opportunities to work together. The World of Difference Summit is built around the theme of partnership – partnership among the corporate for-profit world and non-profits, and partnership among non-profit organizations themselves.
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. The company’s Commercial segment offers insured and self-insured customers medical, dental, behavioral health, and vision, in addition to prescription drug benefit plans, health advocacy programs, and other products and services. Its Government segment offers Medicare Advantage plans to seniors in 16 states and the District of Columbia, Medicare Part D plans in 50 states and the District of Columbia, and Medicaid plans. The company’s Group Disability and Life segment provides group long-term and short-term disability insurance, group life insurance, and accident and specialty insurance.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
